CDKN2A and neoplasm: Finally, copy number analysis showed a significant gain of MDM2 in CDS17 and T-CDS17 cells which was not detected in the tumor sample and a homozygous deletion of CDKN2A (exon 3) in CDS11 cells and matched patient sample (Figure 2B,C).